Biotech · Private company
Alder Biopharmaceuticals, Inc.
Track this companyFree. Adds Alder Biopharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials50 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- ALD403Phase 3 · Migraine DisordersClinicalTrials.gov · fetched Nov 12, 2026
- ALD403 (Eptinezumab)Phase 3 · Migraine DisorderClinicalTrials.gov · fetched Nov 12, 2026
- ALD403 (Eptinezumab)Phase 3 · Migraine DisordersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- A Study to Evaluate the Efficacy and Safety of Eptinezumab Administered Intravenously in Participants Experiencing Acute Attack of MigrainePHASE3 · COMPLETED · started Nov 7, 2019ClinicalTrials.gov NCT04152083 · fetched Nov 12, 2026
- An Open Label Trial of ALD403 (Eptinezumab) in Chronic MigrainePHASE3 · COMPLETED · started Dec 1, 2016ClinicalTrials.gov NCT02985398 · fetched Nov 12, 2026
- Evaluation of ALD403 (Eptinezumab) in the Prevention of Chronic MigrainePHASE3 · COMPLETED · started Nov 1, 2016ClinicalTrials.gov NCT02974153 · fetched Nov 12, 2026
- A Multicenter Assessment of ALD403 in Frequent Episodic MigrainePHASE3 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02559895 · fetched Nov 12, 2026
- A Multicenter Assessment of ALD403 in Chronic MigrainePHASE2 · COMPLETED · started Oct 1, 2014ClinicalTrials.gov NCT02275117 · fetched Nov 12, 2026